Medical network May 11 - since January 9, 2017, the state council reform office issued "on drug procurement in the public medical institutions in implementing the implementation of the" two votes "opinion (try out)", since 4 months passed. Recently, the relevant departments, including the health care reform, have stepped up their efforts to collect the first line of information, and there are signs that there are further adjustments and improvements in the two-ticket policy. 

 

▍ reform is "two votes", about novartis, Pfizer for foreign companies, etc 

 

According to the ministry of commerce, on May 8, the Chinese foreign investment association and the state council reform commission held a meeting on the "two-ticket" issue. 

 

Place yong-feng zhu director introduces the reform do supervision under the state council issued the "two votes" background as well as the purpose and significance, such as snow pock, novartis, Merck and Pfizer 13 multinational drug companies, head of attending to speak and to interact. Lai shiqing, director of the state council's health care reform office, summed up the speech. 

 

The specific content of communication does not have a detailed report, but drug companies for the problems that arise in the implementation of the "two votes" is certainly part of the discussion, it must reform office held two votes, the purpose of project communication meeting and so it does - collection of unexpected problems in the process of policy implementation, prepare the way for further adjustment, perfect. 

 

Similarly, there are sources, on May 5, state development planning commission drug administration department called drug production enterprises, circulation enterprises and medical organizations, the "two votes" symposium. The main purpose of the symposium is to collect the problems in the current policy implementation process, the person said. 

 

▍ the first ticket definition, whether to increase the third ticket, or will be adjusted 

 

In the four months since the country's "two-ticket" policy was announced, there have been a timetable for concrete progress in 18 provinces. But the details of each province are not consistent, for example, the definition of the first ticket: 

 

Zhejiang version will be listed on the licensee as a production enterprise, chongqing will total domestic generation as the first ticket, spread out the guangxi file, also is domestic general agent is regarded as the first ticket. And if the basic medical establishment can add one ticket, the answer in hainan is not, and qinghai is allowed. For such differences, do you want national unity? Maybe it's the next step. 

 

In addition, there are more details, such as the difficulty of living in a "two-ticket" system. Pharmaceutical companies have undertaken the development and maintenance of the secondary channel, increasing the cost. Medical institutions need to check the amount of information, the difficulty, the human cost, etc., and will also be a reference for adjustment. 

 

▍ execution details or adjustment 

 

Some of the area feedback details that have already been implemented in the two-ticket system may need to be adjusted and refined: 

 

For example, how the hospital could make room for a large number of bills and how to confirm the number of tickets. 

 

The distribution problem in remote areas, for example, may be because some provinces limit the number of distributors, causing them to fail to deliver on time. 

 

Even if is a large logistics distribution business, ever also need to rely on a secondary distributors network to achieve full coverage, two votes, after the secondary distributors is not eligible, big business is also difficult to ensure all distribution in place. 

 

And how does a small quantity, shortage of drugs, etc., in the case of a two-ticket, unprofitable picture, and how to reach the medical establishment at the end of the day? 

 

▍ will hit the CSO? 

 

The recent taiyuan, then a two-ticket document in shanxi, has made the industry very public. The document that drew the attention of the drug industry was: 

 

Pharmaceutical, medical consumables production enterprise or the business unit can be considered as production enterprise, shall not entrust technology companies, consulting companies, such as the pharmaceutical trading enterprises in our city marketing and drugs, companies such as can not to pay, covert "money laundering" and increase the drug sales link. 

 

After the release of this policy, interpretation is seen by some as a CSO sales organization (contract) doesn't work, will be banned, and thus cause the extensive concern of the industry. But CSO exists as a sales model and does not violate the rules. It is the group that is in the name of CSO that is involved in money laundering. No official document has yet been made to crack down on the real CSO. 

 

So how does the CSO, the regulated CSO do, and whether the policy changes will involve CSO? 

 

▍ department: there is a problem, it should be adjusted in a timely manner 

 

In fact, the "two-ticket" policy is highly likely to be adjusted. Handle in the health of the policy issued on January 9, the opening is mentioned "can be combined with the actual formulate detailed rules for the implementation, the execution of new situation and new problems, please report to the reform of the state council office. According to the trial conditions of medical reform office will jointly with the relevant departments under the state council, further improve relevant policies." 

 

In other words, the country has made room for further adjustment and improvement of the policy. Comprehensive days, health care and foreign exchanges, as well as rumours of drug administration department of the "two votes" symposium judge speculated that the window of the policy adjustment, is expected to open soon. 

 

According to past experience, the policy adjustment may be a supplementary explanation, or a reply to a question. The details will be adjusted, and cypress blue will remain focused. 

 

Jilin, liaoning, heilongjiang, Shanghai, anhui, shanxi, hunan, hainan, chongqing, sichuan, qinghai, ningxia, guangdong and so on more than a dozen provinces have issued two votes policy, landing in a ticket business closures, precipice agent ticket channels to be sealed. At the same time, the doctor practicing open high-profile foray into circulation, third-party medical logistics distribution, rapid advance payment reform policies such as the traditional model of the enterprise to bring significant impact. In the future, how will the two-ticket policy be adjusted?